Koninklijke Philips (NYSE:PHG) Shares Acquired by Creative Planning

Creative Planning increased its position in shares of Koninklijke Philips (NYSE:PHG - Free Report) by 39.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 84,263 shares of the technology company's stock after purchasing an additional 23,768 shares during the period. Creative Planning's holdings in Koninklijke Philips were worth $2,757,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of PHG. Mondrian Investment Partners LTD increased its stake in Koninklijke Philips by 45.1% in the first quarter. Mondrian Investment Partners LTD now owns 9,553,058 shares of the technology company's stock valued at $191,061,000 after purchasing an additional 2,971,008 shares during the last quarter. Dimensional Fund Advisors LP grew its position in shares of Koninklijke Philips by 27.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 4,036,336 shares of the technology company's stock valued at $101,718,000 after buying an additional 864,951 shares during the last quarter. Russell Investments Group Ltd. grew its position in shares of Koninklijke Philips by 36.4% in the 1st quarter. Russell Investments Group Ltd. now owns 1,410,067 shares of the technology company's stock valued at $28,201,000 after buying an additional 376,244 shares during the last quarter. Millennium Management LLC raised its stake in Koninklijke Philips by 822.0% during the 2nd quarter. Millennium Management LLC now owns 1,120,521 shares of the technology company's stock worth $28,237,000 after acquiring an additional 998,995 shares in the last quarter. Finally, Natixis Advisors LLC lifted its position in Koninklijke Philips by 5.2% in the second quarter. Natixis Advisors LLC now owns 930,085 shares of the technology company's stock valued at $23,438,000 after acquiring an additional 46,268 shares during the last quarter. Hedge funds and other institutional investors own 13.67% of the company's stock.

Analyst Ratings Changes

Separately, StockNews.com raised Koninklijke Philips from a "hold" rating to a "buy" rating in a report on Monday, July 15th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, Koninklijke Philips has a consensus rating of "Hold".

Koninklijke Philips Stock Performance

NYSE PHG traded down $0.52 on Friday, reaching $31.67. The stock had a trading volume of 895,979 shares, compared to its average volume of 962,068. The stock has a market cap of $29.77 billion, a P/E ratio of -32.99, a price-to-earnings-growth ratio of 1.05 and a beta of 0.74. Koninklijke Philips has a 12-month low of $18.06 and a 12-month high of $32.91. The business's 50-day moving average price is $31.10 and its 200 day moving average price is $27.79. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.74 and a current ratio of 1.16.

Koninklijke Philips (NYSE:PHG - Get Free Report) last released its quarterly earnings results on Monday, July 29th. The technology company reported $0.32 EPS for the quarter. The firm had revenue of $4.80 billion during the quarter. Koninklijke Philips had a negative net margin of 2.35% and a positive return on equity of 10.15%. As a group, equities analysts expect that Koninklijke Philips will post 1.59 earnings per share for the current year.

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.